Correction to: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia

被引:0
|
作者
Hannah A. Blair
机构
[1] Springer,
来源
Drugs | 2018年 / 78卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The original article has been corrected.
引用
收藏
页码:1911 / 1911
相关论文
共 50 条
  • [1] Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
    Blair, Hannah A.
    DRUGS, 2018, 78 (18) : 1903 - 1910
  • [2] Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
    Murphy, Tracy
    Yee, Karen W. L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1765 - 1780
  • [3] Effect of cloretazine on acute myeloid leukaemia blasts in vitro -: as a single agent and combined with cytarabine and daunorubicin
    Morris, K. L.
    Wren, D.
    Adams, J. A.
    Yin, J. A. Liu
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 23 - 23
  • [4] Effect of cloretazine on acute myeloid leukaemia blasts in vitro as a single agent and combined with cytarabine and daunorubicin
    Morris, K.
    Wren, D.
    Adams, J. A.
    Yin, J. A. Liu
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 412 - 412
  • [5] Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine
    Yu-Yan Hwang
    Po Tsui
    Rock Y. Y. Leung
    Yok-Lam Kwong
    Annals of Hematology, 2013, 92 : 267 - 268
  • [6] Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine
    Hwang, Yu-Yan
    Tsui, Po
    Leung, Rock Y. Y.
    Kwong, Yok-Lam
    ANNALS OF HEMATOLOGY, 2013, 92 (02) : 267 - 268
  • [7] Clofarabine and cytarabine for acute myeloid leukaemia
    Stirrups, Robert
    LANCET ONCOLOGY, 2019, 20 (08): : E402 - E402
  • [8] CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
    Lancet, Jeffrey E.
    Uy, Geoffrey L.
    Cortes, Jorge E.
    Newell, Laura F.
    Lin, Tara L.
    Ritchie, Ellen K.
    Stuart, Robert K.
    Strickland, Stephen A.
    Hogge, Donna
    Solomon, Scott R.
    Stone, Richard M.
    Bixby, Dale L.
    Kolitz, Jonathan E.
    Schiller, Gary J.
    Wieduwilt, Matthew J.
    Ryan, Daniel H.
    Hoering, Antje
    Banerjee, Kamalika
    Chiarella, Michael
    Louie, Arthur C.
    Medeiros, Bruno C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (26) : 2684 - +
  • [9] Resistance Mechanism of Acute Myeloid Leukemia Cells Against Daunorubicin and Cytarabine: A Literature Review
    Arwanih, Elly Y.
    Louisa, Melva
    Rinaldi, Ikhwan
    Wanandi, Septelia I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [10] COST-EFFECTIVENESS ANALYSIS OF GEMTUZUMAB OZOGAMICIN IN COMBINATION WITH DAUNORUBICIN AND CYTARABINE FOR THE TREATMENT OF ACUTE MYELOID LEUKAEMIA IN PORTUGAL
    Paquete, A. T.
    Ines, M.
    Borges, M.
    Silva Miguel, L.
    VALUE IN HEALTH, 2020, 23 : S469 - S470